The tumor suppressor merlin is required for cell cycle exit, terminal differentiation, and cell polarity in the developing murine lens

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3611-3618

  Wiley, Luke A ^a   Dattilo, Lisa K ^a   Kang, Kai B ^a   Giovannini, Marco ^b   Beebe, David C ^a,c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; FOXE3; MERLIN; PROTEIN ZO1; PROX1; UNCLASSIFIED DRUG; UVOMORULIN; BIOLOGICAL MARKER; CADHERIN; FORKHEAD TRANSCRIPTION FACTOR; FOXE3 PROTEIN, MOUSE; MEMBRANE PROTEIN; PHOSPHOPROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; BASEMENT MEMBRANE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL JUNCTION; CELL POLARITY; CELL STRUCTURE; CONTROLLED STUDY; CORNEA EPITHELIUM; ECTODERM; EMBRYO; EYE DEVELOPMENT; FEMALE; GENE DELETION; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LENS; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSGENE; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENOTYPE; MALE; METABOLISM; MOUSE MUTANT; NICK END LABELING; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMALS; BIOLOGICAL MARKERS; CADHERINS; CELL CYCLE; CELL DIFFERENTIATION; CELL POLARITY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; GENOTYPE; IN SITU NICK-END LABELING; LENS, CRYSTALLINE; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEUROFIBROMIN 2; PHOSPHOPROTEINS; PREGNANCY;

EID: 77955889184     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4371     Document Type: Article

References (43)

1. Saito H, Yoshida T, Yamazaki H, Suzuki N. Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model. Oncogene. 2007;26:4714-4719.
2. Gautreau A, Manent J, Fievet B, Louvard D, Giovannini M, Arpin M. Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway. J Biol Chem. 2002;277: 31279-31282.
3. McClatchey AI. Neurofibromatosis. Annu Rev Pathol. 2007;2:191-216.
4. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 2003;17:1090-1100.
5. McLaughlin ME, Kruger GM, Slocum KL, et al. The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. Proc Natl Acad Sci U S A. 2007;104:3261-3266.
6. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol. 2007;177:893-903.
7. Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem. 1994;269:23387-23390.
8. Rong R, Tang X, Gutmann DH, Ye K. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A. 2004;101: 18200-18205.
9. Chadee DN, Xu D, Hung G, et al. Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci U S A. 2006;103:4463-4468.
10. Robman L, Taylor H. External factors in the development of cataract. Eye. 2005;19:1074-1082.
11. Streeten BW, Eshaghian J. Human posterior subcapsular cataract: a gross and flat preparation study. Arch Ophthalmol. 1978;96:1653-1658.
12. Eshaghian J, Streeten BW. Human posterior subcapsular cataract: an ultrastructural study of the posteriorly migrating cells. Arch Ophthalmol. 1980;98:134-143.
13. Giovannini M, Robanus-Maandag E, van der Valk M, et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 2000;14:1617-1630.
14. Ashery-Padan R, Marquardt T, Zhou X, Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev. 2000;14:2701-2711.
15. Rajagopal R, Dattilo LK, Kaartinen V, et al. Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survival. Invest Ophthalmol Vis Sci. 2008;49:4953-4960.
16. Zhang P, Wong C, DePinho RA, Harper JW, Elledge SJ. Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev. 1998;12: 3162-3167.
17. Landgren H, Blixt A, Carlsson P. Persistent FoxE3 expression blocks cytoskeletal remodeling and organelle degradation during lens fiber differentiation. Invest Ophthalmol Vis Sci. 2008;49: 4269-4277.
18. Wigle JT, Chowdhury K, Gruss P, Oliver G. Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet. 1999;21:318-322.
19. Ring BZ, Cordes SP, Overbeek PA, Barsh GS. Regulation of mouse lens fiber cell development and differentiation by the Maf gene. Development. 2000;127:307-317.
20. Yoshida K, Kim JI, Imaki J, et al. Proliferation in the posterior region of the lens of c-maf-/- mice. Curr Eye Res. 2001;23:116-119
21. King LS, Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol. 1996;58:619-648.
22. Broekhuyse RM, Kuhlmann ED, Stols AL. Lens membranes II: isolation and characterization of the main intrinsic polypeptide (MIP) of bovine lens fiber membranes. Exp Eye Res. 1976;23:365-371.
23. Nguyen MM, Rivera C, Griep AE. Localization of PDZ domain containing proteins Discs Large-1 and Scribble in the mouse eye. Mol Vis. 2005;11:1183-1199
24. Nielsen PA, Baruch A, Shestopalov VI, et al. Lens connexins alpha3Cx46 and alpha8Cx50 interact with zonula occludens pro-tein-1 (ZO-1). Mol Biol Cell. 2003;14:2470-2481.
25. Cvekl A, Tamm ER. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. Bioessays. 2004;26:374-386.
26. Schook P. A review of data on cell actions and cell interaction during the morphogenesis of the embryonic eye. Acta Morphol Neerl Scand. 1978;16:267-286.
27. Webster EH Jr, Silver AF, Gonsalves NI. The extracellular matrix between the optic vesicle and presumptive lens during lens morphogenesis in an anophthalmic strain of mice. Dev Biol. 1984;103: 142-150.
28. Mizuno S, Ikeda K, Majima A, Hirabayashi Y, Yamada K. [Histo-chemical studies on the separation of the lens vesicle]. Nippon Ganka Gakkai Zasshi. 1997;101:46-51.
29. Mohamed YH, Amemiya T. Apoptosis and lens vesicle development. Eur J Ophthalmol. 2003;13:1-10.
30. Bassnett S. On the mechanism of organelle degradation in the vertebrate lens. Exp Eye Res. 2009;88:133-139
31. Liu Y, Zacksenhaus E. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb-deficient fetuses. Oncogene. 2000; 19:6065-6073
32. Pan H, Griep AE. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 1995;9:2157-2169.
33. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. P53-depen-dent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 1994;371:72-74.
34. Gutmann DH, Haipek CA, Burke SP, Sun CX, Scoles DR, Pulst SM. The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility. Hum Mol Genet. 2001;10:825-834.
35. Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH. The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Mol Cell Biol. 2009;29: 1472-1486.
36. Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia. 2008;10:1204-1212.
37. Zhang P, Liegeois NJ, Wong C, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 1997;387:151-158.
38. Prosser J, van Heyningen V. PAX6 mutations reviewed. Hum Mutat. 1998;11:93-108.
39. Medina-Martinez O, Brownell I, Amaya-Manzanares F, Hu Q, Behringer RR, Jamrich M. Severe defects in proliferation and differentiation of lens cells in Foxe3 null mice. Mol Cell Biol. 2005;25:8854-8863.
40. Pontoriero GF, Smith AN, Miller LA, Radice GL, West-Mays JA, Lang RA. Co-operative roles for E-cadherin and N-cadherin during lens vesicle separation and lens epithelial cell survival. Dev Biol. 2009; 326:403-417.
41. Pontoriero GF, Deschamps P, Ashery-Padan R, et al. Cell autonomous roles for AP-2a in lens vesicle separation and maintenance of the lens epithelial cell phenotype. Dev Dyn. 2008;237:602-617.
42. Heckenlively J, Kielar R. Congenital perforated cornea in Peter's anomaly. Am J Ophthalmol. 1979;88:63-65.
43. Blixt A, Landgren H, Johansson BR, Carlsson P. Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev Biol. 2007;302: 218-229